172 related articles for article (PubMed ID: 18248772)
1. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S
Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772
[TBL] [Abstract][Full Text] [Related]
2. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
3. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
[TBL] [Abstract][Full Text] [Related]
5. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
[TBL] [Abstract][Full Text] [Related]
6. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
7. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
[TBL] [Abstract][Full Text] [Related]
8. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
9. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
10. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
11. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
[TBL] [Abstract][Full Text] [Related]
12. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
13. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
14. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.
Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350
[TBL] [Abstract][Full Text] [Related]
15. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
[TBL] [Abstract][Full Text] [Related]
16. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
17. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
[TBL] [Abstract][Full Text] [Related]
18. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
19. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I
Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
[TBL] [Abstract][Full Text] [Related]
20. CARD15 variants in patients with sporadic Parkinson's disease.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
